Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Substance Withdrawal Syndrome × Dasatinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Breast Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Leukemia 11 Leukemia, Myeloid, Chronic-Phase 10 Prostatic Neoplasms 8 Recurrence 6 Lung Neoplasms 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 5 Burkitt Lymphoma 5 Melanoma 4 Glioblastoma 4 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Leukemia, Myeloid, Acute 3 Gliosarcoma 3 Blast Crisis 3 Sarcoma 2 Salivary Gland Neoplasms 2 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Polycythemia Vera 2 Oligodendroglioma 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2

Interventions

morphine, naltrexone combination 1 Naltrexone 1 Morphine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡